ASPM and lung carcinoma: In addition to our findings on LMO1, we identified five genes (GNG4, NCAPG, SPC25, ASPM and KIF2C) that are expressed at higher levels in lung tumors relative to NATs and are significantly correlated with poor survival of lung cancer patients, suggesting possible oncogenic functions in lung cancer.